BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20424133)

  • 1. Is prostate cancer prevention with selenium all in the genes?
    Platz EA
    Cancer Prev Res (Phila); 2010 May; 3(5):576-8. PubMed ID: 20424133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
    Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
    Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets of selenium in prostate cancer prevention (Review).
    Abdulah R; Kobayashi K; Yamazaki C; Koyama H
    Int J Oncol; 2011 Aug; 39(2):301-9. PubMed ID: 21567081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
    Platz EA; Lippman SM
    J Clin Oncol; 2009 Aug; 27(22):3569-72. PubMed ID: 19528369
    [No Abstract]   [Full Text] [Related]  

  • 6. Selenium and prostate cancer prevention.
    Nelson MA; Porterfield BW; Jacobs ET; Clark LC
    Semin Urol Oncol; 1999 May; 17(2):91-6. PubMed ID: 10332922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
    Marshall JR
    Nutr Cancer; 2001; 40(1):74-7. PubMed ID: 11799927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
    Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
    Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: chemoprevention update 2005.
    Fleshner N; Al Azab R
    Can J Urol; 2005 Jun; 12 Suppl 2():2-4. PubMed ID: 16018824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer prevention: past, present, and future.
    Fleshner N; Zlotta AR
    Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hormone-related cancers: prostate cancer.
    Parnes HL; Thompson IM; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
    Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
    Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens and prevention of prostate cancer.
    Sarvis JA; Thompson IM
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):271-7. PubMed ID: 18438176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: a serious disease suitable for prevention.
    Fitzpatrick JM; Schulman C; Zlotta AR; Schröder FH
    BJU Int; 2009 Apr; 103(7):864-70. PubMed ID: 19302133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on chemoprevention for prostate cancer.
    Strope SA; Andriole GL
    Curr Opin Urol; 2010 May; 20(3):194-7. PubMed ID: 20216317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.
    Kote-Jarai Z; Durocher F; Edwards SM; Hamoudi R; Jackson RA; Ardern-Jones A; Murkin A; Dearnaley DP; Kirby R; Houlston R; Easton DF; Eeles R;
    Prostate Cancer Prostatic Dis; 2002; 5(3):189-92. PubMed ID: 12496980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.